# Evanescent extraosseous calcifications in low turnover bone: management and outcomes: a case report

**Authors:** Mariel Hernandez-Pérez, Daniel Enos

PMC · DOI: 10.3389/fneph.2025.1702475 · Frontiers in Nephrology · 2026-01-14

## TL;DR

A young peritoneal dialysis patient with extraosseous calcifications improved after switching to hemodialysis and STS therapy.

## Contribution

Demonstrates effective management of calcifications using STS in a patient with low bone turnover.

## Key findings

- Switching to hemodialysis and STS therapy reduced calcifications in 3 months.
- Patient tolerated treatment well despite marked PTH decrease and swelling.
- Calcifications resolved, suggesting multi-angle intervention is crucial for such cases.

## Abstract

The prevalence of bone disease in peritoneal dialysis patients has been recently shown to exceed 54%, including patients with parathormone (PTH) levels within the theoretical adequate target, yet demonstrating low bone turnover on histomorphometry. Moreover, bone disease is often associated with abnormalities in calcium and phosphate metabolism, leading to tissular deposits such as extraosseous calcifications.

We present a 22-year-old female patient managed on peritoneal dialysis with persistent swelling of all four extremities, including the fingers, hands, and feet, accompanied by a marked decrease in PTH. Many extraosseous calcifications in the hands were seen in the X-ray images, prompting a switch from peritoneal dialysis to conventional high-flow haemodialysis and intravenous sodium thiosulphate (STS) therapy. The patient showed adequate treatment tolerance, with most calcifications disappearing after 3 months of therapy.

Our experience suggests that the treatment of extraosseous calcifications requires timely and multi-angle intervention. At the same time, treatment with STS has proven effective and well tolerated in this patient.

## Linked entities

- **Proteins:** PTH (parathyroid hormone)
- **Chemicals:** sodium thiosulphate (PubChem CID 24477)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** swelling (MESH:D004487), calcifications (MESH:D002114), bone disease (MESH:D001847)
- **Chemicals:** STS (MESH:C017717), calcium (MESH:D002118), phosphate (MESH:D010710)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847024/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12847024/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847024/full.md

---
Source: https://tomesphere.com/paper/PMC12847024